These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population. Cecchi F, Olivotto I, Montereggi A, Squillatini G, Dolara A, Maron BJ. Heart; 1998 Apr; 79(4):331-6. PubMed ID: 9616338 [Abstract] [Full Text] [Related]
12. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. Monserrat L, Elliott PM, Gimeno JR, Sharma S, Penas-Lado M, McKenna WJ. J Am Coll Cardiol; 2003 Sep 03; 42(5):873-9. PubMed ID: 12957435 [Abstract] [Full Text] [Related]
13. Spatial QT Dispersion Predicts Nonsustained Ventricular Tachycardia and Correlates with Confined Systodiastolic Dysfunction in Hypertrophic Cardiomyopathy. Magrì D, Piccirillo G, Ricotta A, De Cecco CN, Mastromarino V, Serdoz A, Muscogiuri G, Gregori M, Casenghi M, Cauti FM, Oliviero G, Musumeci MB, Maruotti A, Autore C. Cardiology; 2015 Sep 03; 131(2):122-9. PubMed ID: 25925893 [Abstract] [Full Text] [Related]
14. Rapid Device-Detected Nonsustained Ventricular Tachycardia in the Risk Stratification of Hypertrophic Cardiomyopathy. Viswanathan K, Suszko AM, DAS M, Jackson N, Gollob M, Cameron D, Spears D, Woo A, Rakowski H, Khurana M, Chauhan VS. Pacing Clin Electrophysiol; 2016 Jul 03; 39(7):642-51. PubMed ID: 27027856 [Abstract] [Full Text] [Related]
20. Correlations between cardiac troponin I and nonsustained ventricular tachycardia in hypertrophic obstructive cardiomyopathy. Liu L, Liu S, Shen L, Tu B, Hu Z, Hu F, Zheng L, Ding L, Fan X, Yao Y. Clin Cardiol; 2020 Oct 01; 43(10):1150-1159. PubMed ID: 32810305 [Abstract] [Full Text] [Related] Page: [Next] [New Search]